MTOR and leukemia: Emerging evidence suggests that this pathway may interact with the PI3K/Akt/mTOR pathway, which is known as a modulator of cell growth, metabolism, and survival, and its dysregulation is often associated with leukemia, where it drives clonal expansion of malignant cells.